Moleculin Reports Full Year 2023 Financial Results

– Year marked by growing body of positive Annamycin efficacy and safety clinical data expected to support advancement into a pivotal study for AML – Company to host conference call and webcast Monday, March 25th at 8:30 AM ET – Company to issue separate clinical trial update press release...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: ERN Source Type: news